Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Peter Clark, MA, MD, FRCP: A Payer Perspective

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




Jul
21
Today In Oncology
Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes
Long-Term Outcomes With SABR in Primary Kidney Cancer
Long-Term Follow-up of Postoperative Chemoradiotherapy With Weekly vs Every-3-Week Cisplatin in Head and Neck Cancer
EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma
Mutant KRAS Vaccine for Prevention of Pancreatic Cancer Development Shows Durable Immune Responses
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo